Expand JAZZ Menu
JAZZ MENU

JAZZ Stock Summary and Trading Ideas (Jazz Pharmaceuticals PLC - | NASDAQ:JAZZ)

Charts for Today's Stock Price and Implied Volatility in Jazz Pharmaceuticals PLC -

13-Nov-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for JAZZ by Theoretical Edge and Win Rates

Sentiment

News

Baupost's top Q3 trades include Jazz exit, new Dollar General stake

Seeking Alpha News (Wed, 13-Nov 5:36 PM ET)

Trading Statistics

Key Ratios

Jazz Pharmaceuticals PLC - (JAZZ) Frequently Asked Questions

What does Jazz Pharmaceuticals PLC - do?

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

What symbol and exchange does Jazz Pharmaceuticals PLC - shares trade?

Jazz Pharmaceuticals PLC - trades on the NASDAQ stock market under the symbol JAZZ.

What is Jazz Pharmaceuticals PLC - stock price doing today?

As of November 13, 2024, JAZZ stock price declined to $127.65 with 779,743 million shares trading.

What is Jazz Pharmaceuticals PLC -'s Beta?

JAZZ has a beta of 0.53, meaning it tends to be less sensitive to market movements. JAZZ has a correlation of 0.05 to the broad based SPY ETF.

How much is Jazz Pharmaceuticals PLC - worth?

JAZZ has a market cap of $7.88 billion. This is considered a Mid Cap stock.

How much money does Jazz Pharmaceuticals PLC - make?

Last quarter Jazz Pharmaceuticals PLC - reported $1 billion in Revenue and $6.61 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $1.11.

What is the highest and lowest price Jazz Pharmaceuticals PLC - traded in the last 3 year period?

In the last 3 years, JAZZ traded as high as $169.98 and as low as $99.06.

What are the top ETFs holding Jazz Pharmaceuticals PLC -?

The top ETF exchange traded funds that JAZZ belongs to (by Net Assets): COWZ, IJH, VTI, VB, VBR.

Is Jazz Pharmaceuticals PLC - (JAZZ) a good investment?

JAZZ has underperformed the market in the last year with a return of +6.2%, while SPY returned +37.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in JAZZ shares. However, JAZZ has outperformed the market in the last 3 month and 2 week periods, returning +18.0% and +14.1%, while SPY returned +12.3% and +2.7%, respectively. This indicates JAZZ has been having a stronger performance recently.

What are the support and resistance levels for Jazz Pharmaceuticals PLC - (JAZZ)?

JAZZ support price is $125.26 and resistance is $130.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JAZZ shares will trade within this expected range on the day.